Renal Cell Carcinoma

The EAU renal cell carcinoma pathway — from clinical suspicion or incidental finding through diagnosis, cT staging and chest imaging, localized treatment (partial/radical nephrectomy, ablation, active surveillance, adjuvant pembrolizumab), follow-up and recurrence, to metastatic care: oligo/metastasis-directed therapy, IMDC risk stratification, and histology-directed systemic therapy for clear-cell and non-clear-cell disease. Switch between the visual Pathway map and the phase-by-phase Explorer.